• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GVC1:GR

1.460 EUR 0.024 1.67%

As of 11:21:54 ET on 12/17/2014.

Snapshot for GenVec Inc (GVC1)

Open: 1.438 Day's Range: 1.414 - 1.493 Volume: 0
Previous Close: 1.436 52wk Range: 1.261 - 3.088 1-Yr Rtn: -9.20%

Stock Chart for GVC1

No chart data available.
  • GVC1:GR 1.493
  • 1D
  • 1M
  • 1Y
1.436
Interactive GVC1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GVC1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1750
Est. PEG Ratio -
Market Cap (M EUR) 25.21
Shares Outstanding (M) 17.27
30 Day Average Volume 126
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GVC1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GVC1

GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. The Company specializes in the treatment of cancers, including pancreatic cancer, esophageal cancer, rectal cancer, and head and neck cancer. The Company is also involved in studies involving hearing loss and balance disorders. GenVec also develops vaccines for infectious diseases.

Douglas J SwirskyPresident/CEO/SecretaryDouglas E BroughChief Scientific Officer
James V LambertCFO/Treasurer/ControllerBryan T ButmanSenior VP:Development
More Company Profile & Key Executives for GVC1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil